Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Launches
Pharma
As questions swirl, Alnylam eyes ATTR market leadership by 2030
Alnylam aspires for Amvuttra to become the revenue leader in an expansive ATTR-CM market of more than 75,000 U.S.-treated patients by 2030.
Angus Liu
Mar 26, 2026 2:08pm
Forma Life Sciences launches into class of new CDMOs
Mar 5, 2026 12:42pm
Alnylam hits profitability in Q4 despite Amvuttra revenue miss
Feb 12, 2026 11:05am
Novartis CEO eyes 2026 growth despite record patent cliff
Feb 4, 2026 2:30pm
As CEO, Luke Miels wants GSK to be more 'product-centric'
Feb 4, 2026 9:40am
Top 10 most anticipated drug launches of 2026
Feb 2, 2026 3:00am
